- NEWS FEATURE
How personalized cancer vaccines could keep tumours from coming back

Moderna employees build RNA vaccines tailored to an individual’s tumour at a facility in Norwood, Massachusetts. Credit: Adam Glanzman/Bloomberg/Getty
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 630, 290-292 (2024)
doi: https://doi.org/10.1038/d41586-024-01717-x
References
Weber, J. S. et al. Lancet 403, 632–644 (2024).
Rojas, L. A. et al. Nature 618, 144–150 (2023).
Miller, A. M. et al. Sci. Transl. Med. 16, eabj9905 (2024).